Stocks · News reference
Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that three members of its Board of Directors have converted
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 26, 2026, 1:07 PM
- Checked
- Aug 26, 2026, 1:07 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est
Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.
Read original at benzingaConference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est
Milestone Scientific (AMEX:MLSS) sees Q3 sales of $2.300 million-$2.500 million vs $2.510 million analyst estimate.
Read original at benzinga